• Home
  • Search
  • Microbial Induction of Vascular Pathology in the CNS
  • Open Access IconOpen Access
  • Cite Icon35
  • https://doi.org/10.1007/s11481-010-9208-9Copy DOI Icon

Microbial Induction of Vascular Pathology in the CNS

Show More
  • Abstract
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

The central nervous system (CNS) is a finely tuned organ that participates in nearly every aspect of our day-to-day function. Neurons lie at the core of this functional unit and maintain an active dialogue with one another as well as their fellow CNS residents (e.g. astrocytes, oligodendrocytes, microglia). Because of this complex dialogue, it is essential that the CNS milieu be tightly regulated in order to permit uninterrupted and efficient neural chemistry. This is accomplished in part by anatomical barriers that segregate vascular components from the cerebral spinal fluid (CSF) and brain parenchyma. These barriers impede entry of noxious materials and enable the CNS to maintain requisite protein and ionic balances for constant electrochemical signaling. Under homeostatic conditions, the CNS is protected by the presence of specialized endothelium/epithelium, the blood brain barrier (BBB), and the blood-CSF barrier. However, following CNS infection these protective barriers can be comprised, sometimes resulting in severe neurological complications triggered by an imbalance or blockage of neural chemistry. In some instances, these disruptions are severe enough to be fatal. This review focuses on a selection of microbes (both viruses and parasites) that compromise vascular barriers and induce neurological complications upon gaining access to the CNS. Emphasis is placed on CNS diseases that result from a pathogenic interplay between host immune defenses and the invading microbe.

Similar Papers
  • Research Article

Regulation of Immune Cell Entry into the Central Nervous System

  • Jan 01, 2010
  • Frontiers in Pharmacology
  • Engelhardt Britta
  • Research Article
  • Citations165

Intraventricular Enzyme Replacement Improves Disease Phenotypes in a Mouse Model of Late Infantile Neuronal Ceroid Lipofuscinosis

  • Apr 01, 2008
  • Molecular Therapy
  • Michael Chang +7
  • Abstract
  • Citations22

Safety and Efficacy of Blinatumomab in Patients with Central Nervous System (CNS) Disease: A Single Institution Experience

  • Nov 29, 2018
  • Blood
  • Mansour Alfayez +18
  • Research Article
  • Citations4

XVI. CNS prophylaxis in aggressive lymphomas: for whom and how

  • Jun 01, 2013
  • Hematological Oncology
  • Giulia Benevolo +2
  • PDF
  • Research Article
  • Citations602

Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms.

  • Dec 30, 2020
  • CNS neuroscience & therapeutics
  • Xiaowen Huang +2
  • Research Article
  • Citations252

Involvement of the choroid plexus in central nervous system inflammation.

  • Jan 01, 2000
  • Microscopy Research and Technique
  • Britta Engelhardt +2
  • Research Article
  • Citations159

Ascorbic acid homeostasis in the central nervous system.

  • Oct 01, 1973
  • American Journal of Physiology-Legacy Content
  • R Spector +1
  • Book Chapter
  • Citations10

The Choroid Plexus

  • Jan 01, 2006
  • Cesario V Borlongan +4
  • Research Article
  • Citations220

Gut reactions: How the blood-brain barrier connects the microbiome and the brain.

  • Nov 23, 2017
  • Experimental Biology and Medicine
  • Aric F Logsdon +4
  • Research Article
  • Citations8

Nanocarrier-mediated curcumin delivery: An adjuvant strategy for CNS disease treatment.

  • Dec 06, 2023
  • Experimental biology and medicine (Maywood, N.J.)
  • Sandip Godse +5
  • Research Article

Central nervous system relapse in pediatric acute lymphoblastic leukemia: Should we be making the diagnosis sooner?

  • May 20, 2011
  • Journal of Clinical Oncology
  • A E Aguilar +2
  • Book Chapter
  • Citations6

Transport of the Nucleoside, Thymidine, in the Central Nervous System: The Blood-Cerebrospinal Fluid and Blood-Brain Barriers

  • Jan 01, 1995
  • Sarah A. Williams +2
  • Research Article
  • Citations56

Understanding the functions of endogenous and exogenous tissue-type plasminogen activator during stroke.

  • Nov 13, 2014
  • Stroke
  • Fabian Docagne +4
  • Research Article
  • Citations4

Conventional Tumor Markers in Cerebralspinal Fluid in Patients with Elevated Serum Tumor Markers and without Central Nervous System Malignant Diseases.

  • Oct 10, 2016
  • Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
  • Zhijie Liu +4
  • Research Article

Abstract PS1-09-07: Central nervous system disease in patients with metaplastic breast cancer receiving antibody drug conjugates: a multi-institutional study

  • Feb 17, 2026
  • Clinical Cancer Research
  • S Premji +12
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.